What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower
Indices Around The Globe
S&P 500 Futures about flat, rebounded off 3,785 session low
UK's FTSE 100 down 2.57%
Japan's Nikkei 225 down 4%
Bonds
10-year treasury yield at 1.50%
Commodities
Crude oil down ~1.80% to near $62.43/barrel
Gold down 2.39% to near $1,727/oz.
Silver down 3.88% to near $26.33/oz.
Crypto
Bitcoin down 7% over last 24 hours to around $47,984.
Top News
The 10-year treasury remains at one-year highs.
Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine expected to receive European Union approval in early March. Also, The Biden Administration is said to be preparing a messaging campaign around Johnson & Johnson’s Janssen vaccine. The White House is reportedly really worried about the concern that the Janssen vaccine is less effective than Pfizer-BioNTech’s and Moderna’s vaccine.
Eli Lilly (NYSE: LLY) announced additional doses of neutralizing antibody therapy to treat COVID-19 purchased by the U.S. government. The company reported a purchase agreement of $210 million, for 100,000 doses of bamlanivimab 700 mg, and etesevimab 1400 mg, together.
U.S. President Biden won’t overrule parliamentarians minimum wage ruling. Senate Parliamentarian Elizabeth MacDonough made her decision Thursday afternoon, declaring the U.S. Senate cannot vote on a federal minimum wage increase.
Earnings season tapering off. Thursday was the busiest day of the fourth-quarter earnings season, with highlights from Salesforce.com (NYSE: CRM), HP (NYSE: HPQ), Moderna (NASDAQ: MRNA), Beyond Meat (NASDAQ: BYND), Workday (NASDAQ: WDAY), First Solar (NASDAQ: FSLR), DoorDash (NASDAQ: DASH) and Airbnb (NASDAQ: ABNB).
See more from Benzinga
Pfizer's 20-Valent Pneumococcal Vaccine Application Accepted EU Review
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.